This Nature Outlook is editorially independent, produced with financial support from a third party. About this content.
Nature is pleased to acknowledge financial support from Abbott in producing this Outlook. The sponsor retains sole responsibility for the following message.
Abbott creates life changing products – in diagnostics, medical devices, nutrition and branded generic pharmaceuticals – that help people and their families lead healthier lives. For diagnostics, Abbott aims to provide accurate tools that enable smarter, faster decisions and transform the way health care providers are managing patients. Abbott’s technology spans the world of healthcare operations - with medical diagnostic instruments, tests, automation and informatics solutions for hospitals, reference labs, blood centers, emergency departments, physician offices and clinics. In line with this commitment, Abbott strives to develop products to reduce the number one cause of mortality worldwide, cardiovascular disease (CVD). To address this disease burden Abbott developed a cardiac specific biomarker, High Sensitivity Troponin I (Hs-cTnI), to help doctors more accurately predict the risk of a heart attack or other cardiac event in the apparently healthy population.